Literature DB >> 29069522

Renal replacement modality and stroke risk in end-stage renal disease-a national registry study.

Mark Findlay1,2, Rachael MacIsaac1, Mary Joan MacLeod3,4, Wendy Metcalfe5,6, Jamie P Traynor2,6, Jesse Dawson1,2, Patrick B Mark1,2.   

Abstract

Background: The risk of stroke in end-stage renal disease (ESRD) on renal replacement therapy (RRT) is up to 10-fold greater than the general population. However, whether this increased risk differs by RRT modality is unclear.
Methods: We used data contained in the Scottish Renal Registry and the Scottish Stroke Care Audit to identify stroke in all adult patients who commenced RRT for ESRD from 2005 to 2013. Incidence rate was calculated and regression analyses were performed to identify variables associated with stroke. We explored the effect of RRT modality at initiation and cumulative dialysis exposure by time-dependent regression analysis, using transplant recipients as the reference group.
Results: A total of 4957 patients commenced RRT for ESRD. Median age was 64.5 years, 41.5% were female and 277 patients suffered a stroke (incidence rate was 18.6/1000 patient-years). Patients who had stroke were older, had higher blood pressure and were more likely to be female and have diabetes. On multivariable regression older age, female sex, diabetes and higher serum phosphate were associated with risk of stroke. RRT modality at initiation was not. On time-dependent analysis, haemodialysis (HD) exposure was independently associated with increased risk of stroke. Conclusions: In patients with ESRD who initiate RRT, HD use independently increases risk of stroke compared with transplantation. Use of peritoneal dialysis did not increase risk on adjusted analysis.

Entities:  

Mesh:

Year:  2018        PMID: 29069522     DOI: 10.1093/ndt/gfx291

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Investigating the Relationship between Cerebral Blood Flow and Cognitive Function in Hemodialysis Patients.

Authors:  Mark Duncan Findlay; Jesse Dawson; David Alexander Dickie; Kirsten P Forbes; Deborah McGlynn; Terry Quinn; Patrick B Mark
Journal:  J Am Soc Nephrol       Date:  2018-12-07       Impact factor: 10.121

2.  Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL Trial.

Authors:  Patrick B Mark; Pardeep S Jhund; Matthew R Walters; Mark C Petrie; Albert Power; Claire White; Michele Robertson; Eugene Connolly; Stefan D Anker; Sunil Bhandari; Kenneth Farrington; Philip A Kalra; Charles R V Tomson; David C Wheeler; Christopher G Winearls; John J V McMurray; Iain C Macdougall; Ian Ford
Journal:  Kidney360       Date:  2021-09-16

3.  Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study.

Authors:  James Tollitt; Aghogho Odudu; Emma Flanagan; Rajkumar Chinnadurai; Craig Smith; Philip A Kalra
Journal:  BMC Nephrol       Date:  2019-11-27       Impact factor: 2.388

4.  Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China.

Authors:  Yanbing Chen; Xiaojiang Zhan; Qing Zhao; Xin Wei; Jun Xiao; Caixia Yan; Wei Zhang
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.